Cu64 Dotatate
Drug
Curium US LLC
Total Payments
$42,074
Transactions
77
Doctors
10
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $42,074 | 77 | 10 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $29,500 | 8 | 70.1% |
| Travel and Lodging | $9,533 | 34 | 22.7% |
| Food and Beverage | $3,041 | 35 | 7.2% |
Top Doctors Receiving Payments for Cu64 Dotatate
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Surgical Oncology | Denver, CO | $6,370 | 11 |
| , M.D | Hematology & Oncology | Lexington, KY | $5,212 | 9 |
| , M.D | Nuclear Radiology | San Francisco, CA | $5,198 | 11 |
| , M.D | Internal Medicine | Rochester, MN | $5,015 | 9 |
| , MD | Internal Medicine | Philadelphia, PA | $4,986 | 8 |
| , D.O | Internal Medicine | Kenner, LA | $4,921 | 10 |
| , M.D | Hematology & Oncology | Albuquerque, NM | $4,702 | 8 |
| , M.D., PH.D | Nuclear Medicine | Portland, OR | $4,690 | 9 |
| , MD, PHD | Nuclear Imaging & Therapy | New York, NY | $491.60 | 1 |
| , M.D | Medical Oncology | Houston, TX | $487.60 | 1 |
Ad
Manufacturing Companies
- Curium US LLC $42,074
Product Information
- Type Drug
- Total Payments $42,074
- Total Doctors 10
- Transactions 77
About Cu64 Dotatate
Cu64 Dotatate is a drug associated with $42,074 in payments to 10 healthcare providers, recorded across 77 transactions in the CMS Open Payments database. The primary manufacturer is Curium US LLC.
Payment data is available from 2019 to 2019. In 2019, $42,074 was paid across 77 transactions to 10 doctors.
The most common payment nature for Cu64 Dotatate is "Consulting Fee" ($29,500, 70.1% of total).